Norditropin
Payments companies reported to CMS as associated with Norditropin. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Norditropin, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Norditropin
These are the largest totals companies reported as associated with Norditropin. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Maria Fleseriu | Portland, OR | Endocrinology, Diabetes & Metabolism | $20,272.11 |
| Philippe Backeljauw | Cincinnati, OH | Pediatric Endocrinology | $18,633.18 |
| Bradley Miller | Minneapolis, MN | Pediatric Endocrinology | $15,208.42 |
| Kevin Yuen | Phoenix, AZ | Endocrinology, Diabetes & Metabolism | $8,935.71 |
| Beverly Biller | Boston, MA | Endocrinology, Diabetes & Metabolism | $6,950.34 |
| David Clemmons | Chapel Hill, NC | Internal Medicine | $6,441.78 |
| Vaneeta Bamba | Philadelphia, PA | Pediatric Endocrinology | $6,021.75 |
| Joshua Yang | Orlando, FL | Pediatric Endocrinology | $5,537.30 |
| Milagros Huerta | Aventura, FL | Pediatric Endocrinology | $5,237.72 |
| Atil Kargi | Chapel Hill, NC | Endocrinology, Diabetes & Metabolism | $5,155.37 |
Prescribed Norditropin?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.